TORONTO (PRWEB)
October 08, 2019

Fewer than 50 percent of preclinical research studies, conducted at a cost of $28 billion per year, are reproducible. Rigor in bioanalytical method validation is emerging in the form of a global standard: preclinical studies are increasingly outsourced (by some estimates, more than half of the time) and senior scientists add the management of an offshore team to their duties.

How can software increase the reproducibility of preclinical research studies amid the shift towards outsourcing and the convergence of regulation and expectations?

Both at the sponsor and the contract service provider, value takes the form of price, delivery time, reputation, transparency and security — the kind of efficiencies a software investment is expected to provide.

Join Graeme Dennis, Commercial Director of Preclinical Pharma at IDBS in a live webinar on Wednesday, October 16, 2019 at 10am EDT (3pm BST/UK) where attendees will learn about:

• 
  What sets apart a successful preclinical informatics implementation
• How the software market has responded to the shift to outsourcing
• Where competitive advantage may be gained for outsourced pharma
• Why software can help improve reproducibility in preclinical studies

This webinar will examine how the deployment of tools in a unit operations or “Workflow-as-a-Service” context can enable reproducible, consistent and transparent work at the scientist bench — while delivering sponsor value at the same time.

For more information or to register for this event, visit Workflow-as-a-Service: Delivering Operational Consistency, Quality & Reproducibility to Preclinical Pharma.

ABOUT IDBS

IDBS helps research and development (R&D) teams around the world make discoveries that have the potential to transform the lives of populations worldwide.

Our advanced scientific informatics platform, The E-WorkBook Cloud, enables organizations to securely capture, manage, share and gain insight from their structured and unstructured data.

Our diverse customer list includes 22 of the top 25 global pharmaceutical companies, and other R&D-driven organizations in biotechnology, agricultural sciences, chemicals, consumer goods, energy, food and beverage, and healthcare.

Privately held since 1989, IDBS joined Danaher’s Life Sciences platform at the end of 2017. IDBS will help provide the foundation for a portfolio of life sciences informatics and knowledge management solutions, within Danaher, that will accelerate the speed of discovering, developing and producing new drugs and therapies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: